Caplin Point Laboratories Limited (CAPLIPOINT.NS)
INR 1869.4
(9.08%)
INR 1869.4
(9.08%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 16.76 Billion | 14.66 Billion | 12.63 Billion | 10.48 Billion | 8.63 Billion | 6.48 Billion |
| Cost of Revenue | 7.56 Billion | 6.63 Billion | 5.6 Billion | 4.75 Billion | 4.16 Billion | 2.9 Billion |
| Gross Profit | 9.2 Billion | 8.03 Billion | 7.02 Billion | 5.73 Billion | 4.46 Billion | 3.58 Billion |
| Operating Expenses | 2.17 Billion | 4.07 Billion | 3.52 Billion | 2.79 Billion | 2.16 Billion | 1.49 Billion |
| Selling, General and Administrative Expenses | 452.7 Million | 1.06 Billion | 504 Million | 346.35 Million | 132.83 Million | 59.89 Million |
| Research and Development Expenses | 737.2 Million | 631.9 Million | 592.7 Million | 536.94 Million | 530.14 Million | 281.86 Million |
| Other Expenses | - | 4.07 Billion | 2.43 Billion | 1.91 Billion | 1.5 Billion | 1.76 Million |
| Cost and Expenses | 9.73 Billion | 10.7 Billion | 9.13 Billion | 7.54 Billion | 6.33 Billion | 4.39 Billion |
| Operating Income | 7.22 Billion | 4.52 Billion | 3.85 Billion | 3.13 Billion | 2.64 Billion | 2.08 Billion |
| Interest Expense | 7.8 Million | 7.8 Million | 7 Million | 15.89 Million | 3.19 Million | 600 Thousand |
| Income Tax Expense | 1.03 Billion | 743.6 Million | 773.7 Million | 621.88 Million | 543.78 Million | 503.2 Million |
| Earnings before Tax | 5.64 Billion | 4.51 Billion | 3.85 Billion | 3.13 Billion | 2.69 Billion | 2.26 Billion |
| Net Income | 4.57 Billion | 3.76 Billion | 2.99 Billion | 2.42 Billion | 2.15 Billion | 1.76 Billion |
| Earnings Per Share Basic | 59.90 | 49.62 | 39.61 | 32.03 | 28.42 | 23.35 |
| Earnings Per Share Diluted | 59.90 | 49.18 | 39.26 | 31.71 | 28.20 | 23.23 |
| Weighted Average Shares Outstanding | 76.3 Million | 75.82 Million | 75.69 Million | 75.64 Million | 75.64 Million | 75.6 Million |
| Weighted Average Shares Outstanding (Diluted) | 76.3 Million | 76.5 Million | 76.36 Million | 76.32 Million | 76.23 Million | 75.99 Million |
| Gross Margin | 0.55 | 0.55 | 0.56 | 0.55 | 0.52 | 0.55 |
| EBIT Margin | 0.37 | 0.34 | 0.34 | 0.33 | 0.34 | 0.38 |
| Profit Margin | 0.27 | 0.26 | 0.24 | 0.23 | 0.25 | 0.27 |
| EBITDA | 6.18 Billion | 4.97 Billion | 4.33 Billion | 3.52 Billion | 3.02 Billion | 2.5 Billion |
| Earnings Before Tax Margin | 0.43 | 0.31 | 0.31 | 0.30 | 0.31 | 0.32 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 4.58 Billion | 14.66 Billion | 3.89 Billion | 4.35 Billion | 4.1 Billion | 3.95 Billion |
| Cost of Revenue | 2.41 Billion | 6.63 Billion | 1.76 Billion | 1.9 Billion | 1.64 Billion | 1.78 Billion |
| Gross Profit | 2.17 Billion | 8.03 Billion | 2.12 Billion | 2.45 Billion | 2.45 Billion | 2.16 Billion |
| Operating Expenses | 815.2 Million | 4.07 Billion | 998.8 Million | 1.17 Billion | 1.2 Billion | 1.01 Billion |
| Selling, General and Administrative Expenses | 623.2 Million | - | 360 Million | 488.6 Million | 556.2 Million | 413.1 Million |
| Research and Development Expenses | 192 Million | - | 244.7 Million | 175.8 Million | 178.6 Million | 138.1 Million |
| Other Expenses | 185.6 Million | 669.4 Million | 172.9 Million | 171.8 Million | 204.3 Million | 120.4 Million |
| Cost and Expenses | 3.23 Billion | 11.96 Billion | 3.24 Billion | 3.07 Billion | 2.84 Billion | 2.8 Billion |
| Operating Income | 1.35 Billion | 3.96 Billion | 1.12 Billion | 1.45 Billion | 1.46 Billion | 1.27 Billion |
| Interest Expense | 500 Thousand | 7.8 Million | 2.3 Million | 1.7 Million | 1.8 Million | 2.8 Million |
| Income Tax Expense | 294.5 Million | 743.6 Million | 228.1 Million | 255.9 Million | 298.6 Million | 227.6 Million |
| Earnings before Tax | 1.54 Billion | 4.51 Billion | 1.24 Billion | 1.45 Billion | 1.46 Billion | 1.26 Billion |
| Net Income | 1.23 Billion | 4.57 Billion | 1.21 Billion | 1.17 Billion | 1.14 Billion | 1.03 Billion |
| Earnings Per Share Basic | 16.32 | - | 13.45 | 15.43 | 15.13 | 13.62 |
| Earnings Per Share Diluted | 16.24 | - | 13.33 | 15.43 | 15.06 | 13.55 |
| Weighted Average Shares Outstanding | 75.96 Million | 75.83 Million | 75.93 Million | 75.94 Million | 75.92 Million | 75.93 Million |
| Weighted Average Shares Outstanding (Diluted) | 76.33 Million | 76.51 Million | 76.61 Million | 75.94 Million | 76.27 Million | 76.33 Million |
| Gross Margin | 0.47 | 0.55 | 0.55 | 0.56 | 0.60 | 0.55 |
| EBIT Margin | 0.33 | - | 0.37 | 0.37 | 0.39 | 0.35 |
| Profit Margin | 0.27 | 0.31 | 0.31 | 0.27 | 0.28 | 0.26 |
| EBITDA | 1.51 Billion | - | 1.45 Billion | 1.59 Billion | 1.57 Billion | 1.38 Billion |
| Earnings Before Tax Margin | 0.30 | 0.27 | 0.29 | 0.33 | 0.36 | 0.32 |
7679
SILLYMONKS
ARASE
FUIG
KDCE
THREL